HCP, Inc. (HCP) Shares Sold by LGT Capital Partners LTD.
LGT Capital Partners LTD. reduced its stake in HCP, Inc. (NYSE:HCP) by 19.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 200,610 shares of the real estate investment trust’s stock after selling 48,910 shares during the period. LGT Capital Partners LTD.’s holdings in HCP were worth $5,603,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. Mount Yale Investment Advisors LLC bought a new position in HCP in the 2nd quarter valued at about $104,000. Peoples Financial Services CORP. raised its holdings in HCP by 87.7% in the 3rd quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock valued at $161,000 after acquiring an additional 2,850 shares during the period. Wetherby Asset Management Inc. bought a new position in HCP in the 3rd quarter valued at about $200,000. Lourd Capital LLC bought a new position in HCP in the 3rd quarter valued at about $211,000. Finally, First Hawaiian Bank bought a new position in HCP in the 3rd quarter valued at about $215,000. 88.83% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HCP traded down $0.06 during mid-day trading on Monday, hitting $28.95. 12,040 shares of the company’s stock were exchanged, compared to its average volume of 3,430,652. HCP, Inc. has a 52 week low of $21.48 and a 52 week high of $30.26. The stock has a market capitalization of $13.56 billion, a PE ratio of 14.78, a P/E/G ratio of 5.37 and a beta of 0.28. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.21.
Several research analysts have weighed in on HCP shares. JPMorgan Chase & Co. cut shares of HCP from an “overweight” rating to a “neutral” rating in a report on Friday, October 5th. Cantor Fitzgerald raised shares of HCP from a “neutral” rating to an “overweight” rating and increased their price target for the company from $28.00 to $29.00 in a report on Thursday, September 27th. Royal Bank of Canada raised shares of HCP from a “sector perform” rating to an “outperform” rating in a report on Friday, November 2nd. ValuEngine raised shares of HCP from a “hold” rating to a “buy” rating in a report on Monday, November 12th. Finally, Bank of America increased their price target on shares of HCP from $27.50 to $28.00 and gave the company a “buy” rating in a report on Monday, September 17th. Three analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $27.39.
In other news, COO Thomas Klaritch sold 82,532 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the transaction, the chief operating officer now directly owns 256,280 shares of the company’s stock, valued at $7,562,822.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.14% of the stock is currently owned by company insiders.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Risk Tolerance
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.